TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Ribozyme Sweden AB
Closing information (x1000 DKK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
7
|
19
|
13 |
| Financial expenses |
0
|
11
|
13 |
| Earnings before taxes |
-8
|
-6
|
-14 |
| EBITDA |
0
|
5
|
-1 |
| Total assets |
963
|
929
|
1,022 |
| Current assets |
46
|
36
|
34 |
| Current liabilities |
599
|
573
|
621 |
| Equity capital |
365
|
356
|
401 |
| - share capital |
66
|
63
|
70 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
37.9%
|
38.3%
|
39.2% |
| Turnover per employee |
7
|
19
|
13 |
| Profit as a percentage of turnover |
-114.3%
|
-31.6%
|
-107.7% |
| Return on assets (ROA) |
-0.8%
|
0.5%
|
-0.1% |
| Current ratio |
7.7%
|
6.3%
|
5.5% |
| Return on equity (ROE) |
-2.2%
|
-1.7%
|
-3.5% |
| Change turnover |
-13
|
8
|
13 |
| Change turnover % |
-67%
|
67% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.